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EDITORIAL REVIEW
Macrophages in acute glomerular inflammation
Blood monocytes migrate into tissues to form a system of
phenotypically diverse macrophages, whose functions range
from degradation of biological debris to mediation of aggressive
inflammation [1]. Macrophages are frequently present in gb-
mcmli in acute proliferative types of human and experimental
glomerulonephritis (ON). This article will focus on recent
developments in our understanding of macrophage involvement
in acute ON, with emphasis on in vivo studies on mechanisms of
macrophage infiltration, the phenotype of macrophages, and the
role of macrophages in acute glomerular inflammation. Earlier
studies which demonstrated the presence of macrophages in
glomerular lesions, and those more recently advocating a role
for macrophages in chronic glomerular scarring will not be
discussed.
Mechanisms of macrophage infiltration
Blood monocytes accumulate in glomerular capillary lumens,
differentiate and infiltrate into the mesangium and, where there
are ruptured capillaries, migrate into Bowman's space. The
mechanisms involved are less well understood than those for
neutrophils, but as for neutrophils, require margination and
attachment to endothelium and movement along chemotactic
gradients [2]. The sequential expression of different adhesion
molecules and chemotactic agents are important factors in
determining the predominant leukocyte type present at different
phases of the inflammatory response.
Adhesion molecules
Adhesion molecules have an important role in leukocyte
infiltration. Their expression and regulation in the kidney have
recently been reviewed [3, 4]. Macrophages express beta 2
leukocyte integrins (LFA-l, CR3 and p150/95), the beta 1
integrin VLA-4, and L-selectin which interact with ligands on
endothelium. The endothelial ligands which appear important in
macrophage trafficking are VCAM1 and ICAM-l [5] and other
as yet unidentified ligands for beta 2 integrins. While many of
these interactions also affect neutrophil infiltration, interaction
between VLA-4 and VCAM appears to be selective for macro-
phages [3]. The change from a predominant neutrophil infiltrate
to a macrophage infiltrate, which starts approximately six hours
after injury, is associated with cytokine-induced changes in
adhesion molecule expression [5], and extravasation of mono-
cytes may be associated with further changes in integrin ex-
pression [6].
The role of these molecules in glomerulonephritis is currently
a major focus of research, and will be clarified further by the
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recent availability of new antibodies and molecular biological
reagents.
The localization of adhesion molecules in rodent glomeruli
relevant to experimental models of glomerulonephntis has
recently been reviewed [3], and is different from that found in
humans (see below). ICAM-l and VCAM expression is found in
the mesangium in the murine glomerulus, and ICAM in glomer-
ular endothelium, podocytes and Bowman's capsular cells in
the rat. There are several recent studies on the vital role of
these molecules in the induction of glomerular injury. In heter-
ologous nephrotoxic nephritis, neutrophil infiltration and pro-
teinuria was dependent on leukocyte B! and B2 integrins and
glomerular expression of ICAM-1 and probably VCAM1 [7].
Renal arterial perfusion with TNF, or TNF antibodies showed
that this enhanced expression of ICAM1 and VCAM1 was
induced by TNF (IL-l had no effects in the model). The authors
speculated that the enhanced expression of ICAM-l and
VCAM- 1, ii persisting into the autologous phase, might be
mechanisms for macrophage recruitment. There are now pub-
lished data on adhesion molecule expression in macrophage-
dependent GN. Kawasaki et al [8] and Nishikawa et al [9] have
reported up-regulation of ICAM- 1 in the glomeruli of WKY rats
during nephrotoxic nephritis, associated with a substantial
increase in monocytes expressing LFA-l. Treatment with
monoclonal antibodies against rat ICAM-! or LFA-1 prevented
development of proteinuria, monocyte influx and subsequent
crescent formation, demonstrating the crucial role of these
adhesion molecules in monocyte accumulation, and again con-
firming the role of macrophages in glomerular injury. LFA-l
and CR3 expression are also present in infiltrating macrophages
in anti-Thyl nephritis (E. de Heer, personal communication).
The role of both ICAM- 1 and VCAM is supported by the finding
of enhanced expression in murine lupus nephritis [3, 10]. In
addition, in vitro inhibition of monocyte binding to cytokine-
stimulated mesangial cells by anti-ICAM-1 antibodies [11] has
been demonstrated. In vitro monocyte binding to glomerular
endothelial cells was inhibited by antibodies against L-selection
[12].
In humans ICAM-l expression is present on normal glomer-
ular endothelium [13—15], and induction is reported on parietal
epithelium and mesangium in diverse types of GN [15]. Con-
versely, VCAM! is present on normal parietal epithelium
[15—17]. In the study of Bruijn and Dinklo [15] this molecule was
reported on capillary walls and mesangium in types of human
GN known to be associated with macrophage infiltration such
as cryogbobulinemia, lupus nephritis, and Wegeners, but not in
membranous nephropathy. These recent studies begin to show
how cytokine-induced changes in specific adhesion molecules
affect macrophage recruitment, an area of glomerular research
where rapid progress can be expected.
Although in vitro cytokines are the most potent inducers of
adhesion through activation of leukocytes and endothelium, in
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vivo changes in capillary flow by vasoactive mediators such as
histamine, platelet activating factor (PAF), eicosanoids, endo-
thelin, and possibly nitric oxide may also favor the arrest and
margination of leukocytes. Chemotactic agents and T cell-
mediated reactions are also essential components in the accu-
mulation of macrophages in glomeruli.
Chemotaxis
Macrophage chemoattractant protein 1 (MCP-1) is a recently
described specific macrophage chemotactic agent, expressed by
a variety of cell types, and stimulated by cytokines [18]. This
protein also regulates adhesion molecule expression in mono-
cytes [19]. A potent in vivo role is suggested by production of
macrophage infiltrates on intradermal injection [20] and the
effects of specific antibodies on immune complex-induced lung
injury [21]. MCP-l is produced by cytokine-stimulated human
[22, 23] and rat [241 mesangial cells, and has been detected in
nephritic glomeruli in accelerated nephrotoxic nephritis (A.
Rees, personal communication). In vitro, mesangial cell MCP-1
is increased by Fc receptor binding to preformed IgG immune
complexes [25], suggesting a mechanism for the previously
reported Fc dependence of macrophage infiltration in autolo-
gous nephrotoxic nephritis [26]. T cells are also a potential
source of MCP-l (see Cell mediated immunity). Of other
possible chemoattractants, complement does not appear to be
involved in glomerular macrophage infiltration [261, and defi-
brination while abrogating crescent formation, does not prevent
intraglomerular macrophage accumulation. A lipid chemoat-
tractant released by nephritic glomeruli has been reported [27]
but is as yet uncharacterized. The role of chemotactic cytokines
has yet to be defined, as does the contribution of eicosanoids,
platelet-derived growth factor (PDGF), thrombin, granulocyte-
macrophage colony stimulating factor (GMCSF) and PAF.
Kinetics
In acute macrophage-dependent GN macrophage influx be-
gins approximately six hours after injury, which is similar to
macrophage infiltration at other inflammatory sites [1]; the
infiltrate peaks at three and four days and slowly declines,
persisting for several weeks in some models. As in granulomas
induced by immunological stimuli the infiltrate is maintained by
the longevity of the macrophages and possibly some ingress of
new monocytes, but with little proliferation, as the proliferative
rate of inflammatory macrophages is very low [1], and most
local proliferation in nephritic glomeruli occurs in intrinsic
glomerular cells [28, 29]. Little is known of the fate of these
macrophages, that is, whether they die in situ, or emigrate.
There is evidence suggesting migration of activated macro-
phages into the periglomerular interstitium [30]. The macro-
phage kinetics in human GN are unknown and cannot be
accurately assessed. Biopsy findings in diffuse endocapillary
GN of post-streptococcal type suggest a possible life span of
around three months [311.
Two other situations where macrophages are found in gb-
meruli are firstly as a transient influx (lasting approximately 24
hours) following systemic macrophage mobilization [32, 33] and
secondly in the normal glomerulus. This small population of
resident macrophages was first described in the rat glomerulus
[34], but is most probably also present in humans [35, 36]. The
turnover time for this population is about four days [37, 38]. Its
role is unknown.
Cell mediated immunity
T cells have a key role in autoimmune diseases [39]. Despite
evidence for this in immune interstitial nephritis [40], until
recently there have been few studies on T cell involvement in
GN [41—43]. Small numbers of T cells are now confirmed in both
experimental [44] and human GN [45—48]. In experimental
antiglomerular basement membrane (GBM) GN the timing of T
cell infiltration and the production of lymphokine have sug-
gested a role for T cells in induction of macrophage infiltration
[44—50]. In this respect, it should be noted that T cells are also
a source of MCP-1. CD 8 cell depletion by monoclonal antibod-
ies in this model in the WKY rat, a highly susceptible strain
which develops a severe crescentic ON, resulted in complete
amelioration of proteinuria and reduction in histological lesions
[51]. The most interesting aspect of this study was that deple-
tion did not affect the early phase of macrophage infiltration,
but only from three days onwards, which suggests different
mechanisms operating at different stages of macrophage infil-
tration. The authors were unable to determine whether the CD
8 positive cells targeted were T cells or NK cells. An essential
cell-mediated component has also been demonstrated in the
autoimmune nephritis in MRL-lpr mice [52]. These recent
results, which are strongly suggestive of an important role for
cell-mediated immunity in some types of ON, should provide a
further impetus to studies in this area.
Macrophage phenotype
Macrophage activation occurs through a complex multistep
process, regulated by a large number of extracellular signals
[53]. In infiltrating macrophages this produces a mixed popula-
tion of responsive, primed and activated macrophages whose
heterogeneity is compounded by the diversity and transience of
activation. There are objective markers for these differing
phenotypes; assessment of some of these in ON shows a high
proportion of primed or activated macrophages. They express
Class II MHC antigens [54, 55], have an enhanced respiratory
burst [55, 56], secrete cytokines [57, 58], plasminogen activator
[59] and characteristic eicosanoids [55], and generate nitric
oxide [60], a recently identified product of activated macro-
phages. The macrophages in crescentic GN are also of activated
type as demonstrated by their high Class II expression and
reaction with monoclonal antibody ED3 [61], and Ram II
expression in the rabbit [62]. In human disease, a significant
proportion of cells expresses IL-2R [48]. The regulation of
macrophage activation in glomenilar inflammation may be
explained by generation of extracellular signals such as cyto-
kines, CSFs, MCP-l, PAF and prostaglandins, all of which
have been identified in nephritic glomeruli or cultured glomer-
ular cells, although which of these factors are involved in vivo
is uncertain. In murine lupus nephritis a role for CSF-l is
suggested by the detection of enhanced CSF- 1 mRNA expres-
sion by glomeruli in the early phase of the nephritis, when
macrophage influx is a prominent feature [63]. Of particular
interest in this study was evidence for a change in glomerular
macrophage phenotype with progression of disease, with mac-
rophages isolated from the early preproteinuric phase showing
CSF-1 dependent proliferation and differentiation. Perhaps the
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most important macrophage activator, yIFN, has not been
demonstrated in GN, although its presence is suggested by the
ameliorative effects of anti-yIFN antibodies in experimental
lupus nephritis [64], and the recognition of T cell infiltration in
the early phases of GN. In normal glomeruli a considerable
proportion of the resident macrophages is also of activated
phenotype expressing MHC Class II antigens and capable of
antigen presentation [65]. Increased Class II expression can be
induced in vivo in this population by administration of yIFN
[661.
Role of macrophages in glomerulonephritis
In this section of the review experiments which have identi-
fied macrophages as mediators of glomerular injury will be
described, followed by discussion of the effector mechanisms
that have been investigated in macrophage-dependent GN, and
the possible role of macrophages in resolution of glomerular
inflammation.
Macrophages mediate glomerular injury
This was first demonstrated in a model of accelerated (autol-
ogous phase) nephrotoxic nephritis in the rat [67], where
macrophage depletion by irradiation markedly reduced protein-
una. Depletion by antimacrophage sera demonstrated similar
macrophage-dependent injury in acute serum sickness [68, 69]
and passive autologous nephrotoxic nephritis [681 in rabbits; in
macrophage-depleted animals injury was partly restored by
macrophage repletion [70]. The injury in these models appears
to be entirely macrophage dependent, and they are therefore
extremely useful systems for defining the effects of macro-
phages in GN. However, two important points must be recog-
nized: firstly, in other models, and almost certainly in most
human GN, the mediators of injury are multiple with evidence
for a macrophage component in combination with other medi-
ators, including complement and neutrophils [71, 72]; secondly,
the index of injury is usually proteinuria. Although this is the
most quantitative measure of injury available, its structural
basis [73] is still uncertain, and it is only one component of
glomerular injury. There is as yet little information on the
effects of macrophages on other aspects of the inflammatory
response and its sequelae.
Effector mechanisms
Apart from their established role in phagocytosis [74], which
is almost certainly an important function of macrophages in
GN, macrophages are effector cells through their secreted
products of which more than a hundred are so far known. Only
a small proportion of these have been studied in macrophage-
dependent GN, and as many are also produced by other cell
types, determining the source of these products is a complex
task. Enzymes, oxygen radicals, PAF, coagulation products,
eicosanoids, and most recently, nitric oxide have been studied
to varying extents. They can somewhat arbitrarily be divided
into factors which might (1) induce tissue injury; (2) participate
in crescent formation; (3) stimulate reactive proliferative or
paracrine responses in glomerular cells; and (4) mediate hemo-
dynamic changes. Clearly, some factors may have several
roles.
Factors inducing tissue injury. In vitro, monocyte neutral
proteinase is a highly effective degrader of GBM, severalfold
more potent than the neutrophil enzyme [75]. There are,
however, scant in vivo data. In one study, in vivo administration
of a protease inhibitor in accelerated nephrotoxic nephritis
clearly reduced proteinuria, although the authors emphasized
that this was not necessarily through direct interference with
enzymes digesting GBM [76]. A possible role has been sug-
gested in the removal of glomerular immune complexes, and
this has been achieved by in vivo administration of a number of
proteolytic enzymes [77].
The evidence that macrophage-derived reactive oxygen spe-
cies effect glomerular injury is indirect, in contrast to strong
evidence for this mechanism in neutrophil-mediated glomerular
damage. Two pieces of evidence suggest a role: one is the
demonstration of macrophage-dependent oxygen radical dam-
age in immune complex lung injury [78] and the second is the
high level of superoxide production in macrophages isolated
from nephritic glomeruli in rat acute in situ immune complex
GN [55] and rabbit accelerated nephrotoxic nephritis [56].
Nitric oxide (NO) is a potent effector molecule produced by
activated macrophages [79, 80]. In these cells it is synthesized
from L-arginine through the action of an inducible nitric oxide
synthase (NOS), recently characterized as a cytochrome P450
type hemoprotein [81]. NOS induction, which requires activa-
tion of macrophages by cytokines [82, 83] or bacterial products
[84], causes prolonged release of NO. The high reactivity of this
transient molecule with complexing to iron-containing groups in
target cells [85, 86] accounts for much of the cytostatic effects
of activated macrophages. In addition, studies in neutrophils
suggest that in leukocytes the combination of NO with simul-
taneously formed reactive oxygen species, forms further toxic
radicals such as peroxynitrite anion [87, 88]. Synthesis of NO
by glomeruli has been demonstrated in several experimental
models of GN in the rat [89—921 (Table 1), and its role in
glomerular pathology recently reviewed [93]. All these models
have a glomerular macrophage infiltrate. At least in Heymann
nephritis, depletion studies show macrophages are the major
source of NO [91]. Elevated urinary excretion of nitrite and
nitrate is also found in nephritic animals, but this reflects
systemic activation by foreign antigen, most probably through
induction of NOS in antigen processing macrophages, and not
renal synthesis [94]. Normal rat glomeruli do not produce basal
NO, as measured by ex vivo nitrite generation, but can be
induced to produce small amounts by high dose LPS—this
effect being due to stimulation of the resident macrophage
population [92]. NO may be an important effector of macro-
phage-dependent GN. It has already been implicated in exper-
imental immune complex injury in the lung [95], and there is
preliminary evidence for effects on the ultrafiltration coefficient
in acute nephrotoxic nephritis [96]. Further studies may reveal
that this pathway is one of the thus far elusive mechanisms by
which macrophages mediate glomerular injury. Certainly the
NO levels in severe models of GN where a substantial macro-
phage infiltrate is present are of the order of those inducing
cytostatic and cytotoxic changes in vitro, and we now have
evidence from immunocytochemistry that the inducible form of
NOS found in macrophages is present in glomeruli in acute in
situ GN induced by cationized IgG (Note added in proof). Other
properties of NO suggest a possible role in leukocyte infiltration
[97], thrombosis [98], hemodynamic changes [99, 100] and
proliferation [101] in GN.
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Table 1. Glomerular NO synthesis in rat models of experimental glomerulonephritis
Model
Max. basal N02 levels
nmolI2000 gloms/48 hr
Macrophage infiltration
cells! glomerulus Effect of irradiation Reference
Accelerated nephrotoxic 158 8 94 18 ND [89]
nephritis
In situ GN, induced by 48.8 22.8 381 64 ND [90]
cationized HuIgG
Active Heymann 7.1 1.4 32 6 Inhibited [91]
nephritis
Anti-Thy 1.1 GN
mesangiolytic phase 8.4 1.8 60 15 ND [92]
mesangial proliferative 1.6 0.4 13 1
phase
Normal glomeruli <1.5




ND is not done.
Crescent formation. The composition of crescents has fasci-
nated renal morphologists and clinicians alike, and some con-
troversy still surrounds this subject, for the mixture of mono-
nucleated cells accumulating in Bowman's space cannot be
characterized by morphology alone. Summarizing the results
from in vitro culture of crescentic glomeruli, enzyme histo-
chemistry, kinetic studies with bone marrow and proliferating
cell labeling, and monoclonal antibodies, it is certain that
crescents are a mixture of glomerular epithelial cells and
macrophages. Which cells predominate, whether this varies
with the age of the crescent, and whether the macrophage
infiltrate comes entirely from within the glomerular capillaries
are still points for discussion, as are possible differences in the
composition of crescents in different diseases, and whether the
epithelial cells are of parietal or visceral origin. Most of these
concerns await answers. However, there is good evidence that
parietal epithelial cells are the most likely source of the epithe-
hal component for firstly, cytokeratin expressed in parietal but
not visceral epithelium is expressed in crescentic cells [102],
and secondly only parietal epithehial cells show a significant
proliferative capacity, as shown by tritated thymidine incorpo-
ration in explanted glomeruli [103] and in vivo in experimental
nephrotoxic nephritis [104]. The stimuli to epithelial cell prolif-
eration have not been extensively studied. Macrophage condi-
tioned medium, epidermal growth factor [105] and thrombin
[106] stimulate proliferation in cultured glomerular epithelium,
but platelet-derived growth factor does not [105]. It is surprising
that fibrin and its products have not been investigated in vitro.
The essential role of fibrin deposition in crescent formation
and the anticoagulant and defibrinating experiments which have
lead to this conclusion have been recently reviewed by Mc-
Clusky and Andres [107]. In macrophage-dependent GN, fibrin
deposition appears to depend on the presence of the macro-
phage infiltrate, through enhanced expression of macrophage
procoagulant activity [59, reviewed in 108]. It is still unclear
whether fibrin formation within Bowman's space is the essential
trigger, or whether intraglomerular fibrin also can stimulate
crescent formation. Capillary rupture is another essential fac-
tor. How these breaks occur are unknown, but weakening
through the direct action of antibody, activity of macrophages,
and increases in intracapillary pressure can all be invoked. The
importance of pressure effects is suggested by the way in which
hypertension can transform a mild form of nephrotoxic nephri-
tis into severe disease with glomerular thrombosis and crescent
formation [109]. The experimental evidence provides a basis for
the following view of crescent formation: activation of mono-
cytes in glomerular capillaries by cytokines and T cells causes
injury and generation of macrophage and possibly endothelial
procoagulants; breaks in the capillary wall, reflecting the sever-
ity of the inflammatory reaction allow egress of fibrin and
macrophages into Bowman's space. Once this occurs, there is
further fibnn deposition and macrophage recruitment through
similar mechanisms, and a reactive proliferation of parietal
epithelium. Later, a collagenous scar replaces the acute inflam-
matory tissue.
Factors stimulating responses in intrinsic glomerular cells.
There are in vivo experiments which suggest that macrophage
infiltration stimulates mesangial proliferation. In an elegant
study of proliferation in acute serum sickness, Hunsicker et al
[110] found that increased thymidine-labeling in glomeruli oc-
curred subsequent to the macrophage influx, and enhanced
outgrowth of mesangial cells has been observed in glomeruli
explanted from nephritic rat kidneys at the height of macro-
phage infiltration [Ill], prevented by prior in vivo macrophage
depletion [112]. Macrophages synthesize several mitogens
known to affect mesangial cell proliferation in vitro. In vivo,
expression of platelet-derived growth factor [113, 114] and
fibroblast growth factor [115] have been reported in mesangial
proliferation, but the source of these mitogens has not been
determined.
Cytokines are implicated in the role of macrophages in GN
through their ability to alter a multitude of cellular functions,
including the macrophage functions referred to in this review,
and functions of intrinsic glomerular cells. They can therefore
have effects on leukocyte infiltration, proteinuria, mesangial
proliferation and matrix production. Although increased ex-
pression of many cytokines has been demonstrated in GN, the
source and in vivo role of most has not been determined, and
this review will focus on in vivo studies which suggest macro-
phages as a source of cytokines in ON. TNF [reviewed in 116]
has the strongest association with macrophage infiltration.
Macrophages isolated from the glomeruhi of MRL!lpr mice
express TNF mRNA, and synthesize TNF [117]. In accelerated
nephrotoxic nephritis not only can the isolated glomerular
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macrophages account for TNF production in nephritic glomer-
uli [581, but anti-TNF antibodies reduce proteinuria in a dose-
dependent manner, and reduce glomerular necrosis [76]. Mac-
rophages are also a source of IL-i in the same models [57, 118,
119], and treatment of accelerated anti-GBM GN in the rat with
IL-i receptor antagonist has recently been reported [120].
Although the effects on interstitial inflammation and renal
function were dramatic, the effect on proteinuria and acute
glomerular lesions was less marked. TGF beta has recently
been shown to have a significant role in the pathogenesis of
anti-Thy 1.1 [121]; the pattern of TGF beta immunostaining in
glomeruli suggests that macrophages are possibly the predom-
inant source. TGF beta mRNA has been extracted from mac-
rophages isolated from glomeruli in accelerated nephrotoxic
nephritis, with results suggesting these cells as the predominant
source in this model [122].
Glomerular hemodynamics. Acute glomerular injury is asso-
ciated with acute, reversible falls in glomerular filtration rate
and renal plasma flow. Enhanced glomerular eicosanoid syn-
thesis, which has been demonstrated in various forms of GN,
has a major role in these hemodynamic changes [reviewed in
123]. The most frequent proffle is that of acute initial production
of lipoxygenase products, with after some hours a more sus-
tained elevation of cyclooxygenase products. Depletion exper-
iments suggest that infiltrating leukocytes are a major source of
some of these products, particularly LTB4 [124—126]. The
changing pattern of eicosanoid generation may not only reflect
differing cellular sources, but also different activation states in
infiltrating leukocytes [55]. The effects of manipulating glomer-
ular eicosanoids are still somewhat controversial, particularly
with regard to possible non-hemodynamic roles in glomerular
injury such as immunoregulation. Some E-series prostaglandins
are anti-inflammatory, and ameliorate both proteinuria and
leukocyte infiltration [127], as does manipulation of dietary
fatty acids [128, 1291. Study on nitric oxide in glomerular
pathophysiology is still in its infancy. It is almost certain that
this molecule has an important role in glomerular hemodynam-
ics in both the normal glomerulus, and in GN. PAF, another
macrophage product also produced by a wide range of other cell
types, has been implicated in immune complex reactions [re-
viewed in 130], particularly its intravascular generation by
sensitized basophils, and platelets in experimental serum sick-
ness. Although systemic infusion produces renal hemodynamic
changes, and intra renal perfusion produces glomerular lesions
with platelet thrombi and leukocyte accumulation, its role in
GN is uncertain. One of its major effects on the glomerulus
when exogenously administered is neutralization of fixed an-
ionic sites on capillary walls, leading to permeability changes
[131]. Thus, the effects of these important mediators may not be
confined to hemodynamics, but may also involve leukocyte
recruitment and structural glomerular changes.
Macrophages promote resolution of glomerular inflammation
In many well-recognized forms of acute inflammation, mac-
rophages, through their ability to lyse fibrin and phagocytose
cellular debris are instrumental in resolution. Acute lobar
pneumonia is an example of this process, and it is notable that
in post-streptococcal GN where there is a substantial macro-
phage infiltrate, the majority of cases undergo complete reso-
lution. Striker, Mannik and Tung [74], based on their earlier
studies on the glomerular deposition of preformed immune
complexes [132], clearly demonstrated macrophage phagocyto-
sis of mesangial immune deposits, using the specific giant
lysosomal marker present in the Chediak-Higashi mouse strain.
Although there is no definite evidence that in immune complex
glomerulonephritis a failure of this mechanism could lead to
progression of disease, one of the central tenants of the patho-
genesis of inflammation is the role of ineffective macrophage
phagocytosis in chronic inflammation. This suggests that in
glomerulonephritis there are instances where macrophage ac-
tivity has a protective effect, and prevents irreversible sequelae
which would result from persistence of inflammatory debris.
Somewhat paradoxically, at least in non-immune models of
glomerular scarring, there is also evidence for a contributory
role for macrophages in progression of disease [133]. This
aspect of macrophage involvement in the inflammatory process
has parallels in other organs, such as the lung and joints.
Further discussion on this extremely important aspect of gb-
merular disease is beyond the scope of this review.
Conclusion
These recent advances in our understanding of how macro-
phages are involved in acute glomerular inflammation clearly
show stages in the pathogenesis of some types of GN which
depend on macrophage accumulation. They show that macro-
phage infiltration is a consequence of interactions between
cytokine-stimulated adhesion molecules on monocytes and
intrinsic glomerular cells, chemoattractant proteins, hemody-
namic changes, and cell-mediated reactions. The resulting
macrophage infiltrate which has a substantial activated compo-
nent is maintained by macrophage longevity and further mono-
cyte recruitment. Our understanding of specific macrophage
products responsible for injury, the mechanisms controlling
macrophage-dependent inflammation, and the possible role of
macrophages in progression to chronic GN is still incomplete,
but will finally provide the scientific basis for therapeutic
intervention in human GN.
VICT0IUA CATTELL
London, England, United Kingdom
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Note added in proof
The in vivo induction of iNOS in nephritic glomeruli has now been
confirmed by immunohistochemistry (see Jansen et a!, Rapid Commu-
nication, this issue). The results also confirm that there is no expression
of iNOS in normal glomeruli. In addition, there is now preliminary
evidence for a role for NO in GN (KETTELER et al, (abstract) JAm Soc
Nephrol 4:610, 1993).
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